Ardent Health, Inc.
ARDT
$8.67
$0.111.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.08% | 8.75% | 11.85% | 4.04% | 19.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.08% | 8.75% | 11.85% | 4.04% | 19.33% |
| Cost of Revenue | -0.39% | 6.57% | 7.63% | 5.82% | 9.34% |
| Gross Profit | 0.14% | 10.46% | 14.96% | 2.70% | 27.33% |
| SG&A Expenses | 6.21% | 9.45% | 6.75% | 3.59% | 6.86% |
| Depreciation & Amortization | 8.41% | 6.49% | 8.25% | 2.40% | 5.20% |
| Other Operating Expenses | 9.03% | 68.83% | 41.95% | 7.33% | 28.85% |
| Total Operating Expenses | 3.56% | 13.11% | 10.16% | 4.91% | 9.76% |
| Operating Income | -33.52% | -76.62% | 34.61% | -11.52% | 501.72% |
| Income Before Tax | -44.77% | -103.86% | 48.44% | 31.18% | 1,794.71% |
| Income Tax Expenses | -31.29% | -130.83% | 72.72% | 42.19% | 1,448.77% |
| Earnings from Continuing Operations | -47.29% | -97.38% | 42.92% | 28.60% | 1,206.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.81% | -25.41% | 5.95% | 6.50% | -78.70% |
| Net Income | -60.64% | -189.20% | 70.56% | 53.00% | 2,849.92% |
| EBIT | -33.52% | -76.62% | 34.61% | -11.52% | 501.72% |
| EBITDA | -25.40% | -48.10% | 27.69% | -7.09% | 214.35% |
| EPS Basic | -61.01% | -186.56% | 53.26% | 37.76% | 2,578.72% |
| Normalized Basic EPS | -53.73% | -247.83% | 71.56% | -16.46% | 646.85% |
| EPS Diluted | -60.58% | -189.47% | 53.26% | 35.20% | 2,551.67% |
| Normalized Diluted EPS | -53.72% | -248.37% | 70.17% | -16.84% | 643.83% |
| Average Basic Shares Outstanding | 0.94% | 3.00% | 11.31% | 11.06% | 11.04% |
| Average Diluted Shares Outstanding | 0.90% | 2.68% | 12.21% | 11.57% | 11.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |